These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34498243)

  • 1. [National consensus created regarding PAH and CTEPH care].
    Rådegran G
    Lakartidningen; 2021 Aug; 118():. PubMed ID: 34498243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
    Godinas L; Sattler C; Lau EM; Jaïs X; Taniguchi Y; Jevnikar M; Weatherald J; Sitbon O; Savale L; Montani D; Simonneau G; Humbert M; Laveneziana P; Garcia G
    J Heart Lung Transplant; 2017 Nov; 36(11):1234-1242. PubMed ID: 28666570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Chazova IE; Martynyuk TV; Valieva ZS; Nakonechnikov SN; Nedogoda SV; Salasyuk AS; Taran IN; Gratsianskaya SE
    Ter Arkh; 2018 Sep; 90(9):101-109. PubMed ID: 30701743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of targeted therapy on circulating progenitor cells in precapillary pulmonary hypertension.
    García-Lucio J; Tura-Ceide O; Del Pozo R; Blanco I; Pizarro S; Ferrer E; Díez M; Coll-Bonfill N; Piccari L; Peinado VI; Barberà JA
    Int J Cardiol; 2017 Feb; 228():238-243. PubMed ID: 27865192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    Akizuki M; Sugimura K; Aoki T; Kakihana T; Tatebe S; Yamamoto S; Sato H; Satoh K; Shimokawa H; Kohzuki M
    Respirology; 2020 Apr; 25(4):427-434. PubMed ID: 31261445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patients' perspective of living with PAH or CTEPH in Sweden].
    Ivarsson B; Hesselstrand R; Rådegran G; Kjellström B
    Lakartidningen; 2019 May; 116():. PubMed ID: 31192407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.
    Wilkens H; Konstantinides S; Lang IM; Bunck AC; Gerges M; Gerhardt F; Grgic A; Grohé C; Guth S; Held M; Hinrichs JB; Hoeper MM; Klepetko W; Kramm T; Krüger U; Lankeit M; Meyer BC; Olsson KM; Schäfers HJ; Schmidt M; Seyfarth HJ; Ulrich S; Wiedenroth CB; Mayer E
    Int J Cardiol; 2018 Dec; 272S():69-78. PubMed ID: 30195840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension.
    Groth A; Saxer S; Bader PR; Lichtblau M; Furian M; Schneider SR; Schwarz EI; Bloch KE; Ulrich S
    Int J Cardiol; 2018 Nov; 270():262-267. PubMed ID: 29891241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
    Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic thromboembolic pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016].
    Wilkens H; Konstantinides S; Lang I; Bunck AC; Gerges M; Gerhardt F; Grgic A; Grohé C; Guth S; Held M; Hinrichs J; Hoeper MM; Klepetko W; Kramm T; Krüger U; Lankeit M; Meyer BC; Olsson KM; Schäfers HJ; Schmidt M; Seyfarth HJ; Ulrich S; Wiedenroth CB; Mayer E
    Dtsch Med Wochenschr; 2016 Oct; 141(S 01):S62-S69. PubMed ID: 27760452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
    Martínez Meñaca A; Blanco Vich I; López Meseguer M; López Reyes R; Bedate Díaz P; Elías Hernández T; Fernández-Cuesta Peñafiel I; Fernández G; Álvez Liste A; Escribano Subías P
    Adv Ther; 2021 Apr; 38(4):1860-1875. PubMed ID: 33675523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.
    Hoette S; Creuzé N; Rochitte CE; Simonneau G; Humbert M; Souza R; Chemla D
    Pulmonology; 2019; 25(4):248-251. PubMed ID: 31080042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension.
    Tanabe N; Sugiura T; Tatsumi K
    Respir Investig; 2013 Sep; 51(3):134-46. PubMed ID: 23978639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
    Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
    Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
    Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
    Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
    Cannon JE; Pepke-Zaba J
    Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
    Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xi Q; Liu Z; Zhao Z; Luo Q; Huang Z
    PLoS One; 2016; 11(1):e0147396. PubMed ID: 26820968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.